HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancer.
Chang HR, Nam S, Kook MC, Kim KT, Liu X, Yao H, Jung HR, Lemos R Jr, Seo HH, Park HS, Gim Y, Hong D, Huh I, Kim YW, Tan D, Liu CG, Powis G, Park T, Liang H, Kim YH.
Chang HR, et al. Among authors: powis g.
Gut. 2016 Jan;65(1):19-32. doi: 10.1136/gutjnl-2014-307918. Epub 2014 Nov 19.
Gut. 2016.
PMID: 25410163
Free PMC article.